Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VIVES Louvain Technology Fund II (VIVES II) is a multi-sector technology transfer fund that invests in high-tech spin-offs and start-ups, with a significant focus on the life sciences and healthcare sectors. Managed by Sopartec, the technology transfer office of UCLouvain, the fund provides seed and early-stage capital to transform academic research into viable commercial enterprises. VIVES II specifically targets innovations in biotechnology, medical devices, and diagnostics, alongside engineering and ICT. The fund acts as a bridge between laboratory research and industrial application, supporting companies through their initial growth phases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VIVES II.